{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:06:48Z","timestamp":1776388008863,"version":"3.51.2"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.eplepsyres.2011.10.001","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T00:50:27Z","timestamp":1322787027000},"page":"88-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Conversion from enzyme-inducing antiepileptic drugs to topiramate: Effects on lipids and c-reactive protein"],"prefix":"10.1016","volume":"98","author":[{"given":"Scott","family":"Mintzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher T.","family":"Skidmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara J.","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Chervoneva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Pequinot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Capuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1528-1157.2003.44802.x","article-title":"Lipoprotein(a) concentration increases during treatment with carbamazepine","volume":"44","author":"Bramswig","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11883-004-0050-5","article-title":"Low-density lipoprotein particle number and risk for cardiovascular disease","volume":"6","author":"Cromwell","year":"2004","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1528-1157.2003.55602.x","article-title":"Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects","volume":"44","author":"Doose","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2006.09.043","article-title":"Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study","volume":"49","author":"El Harchaoui","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0025","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1468-1331.2007.01973.x","article-title":"Topiramate: effects on serum lipids and lipoproteins levels in children","volume":"14","author":"Franzoni","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0030","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jocn.2010.01.045","article-title":"Anthropometric indexes, insulin resistance, and serum leptin and lipid levels in women with cryptogenic epilepsy receiving topiramate treatment","volume":"17","author":"Genc","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0035","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s11745-002-1016-x","article-title":"The role of cytochrome P450 in the regulation of cholesterol biosynthesis","volume":"37","author":"Gibbons","year":"2002","journal-title":"Lipids"},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0040","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1528-1157.1994.tb01792.x","article-title":"Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine","volume":"35","author":"Isojarvi","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0045","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1526-4610.2007.01008.x","article-title":"Serum uric acid and lipid levels while taking topiramate for migraine","volume":"48","author":"Kocer","year":"2008","journal-title":"Headache"},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0050","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1528-1167.2006.00460.x","article-title":"Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine","volume":"47","author":"Mintzer","year":"2006","journal-title":"Epilepsia"},{"issue":"MT50-2","key":"10.1016\/j.eplepsyres.2011.10.001_bib0060","article-title":"The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy","volume":"10","author":"Nikolaos","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1997.tb01123.x","article-title":"Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy","volume":"38","author":"Rosenfeld","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9149(02)02427-X","article-title":"Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial","volume":"90","author":"Rosenson","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0075","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1528-1167.2009.02024.x","article-title":"Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis","volume":"50","author":"Tan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2011.05.014","article-title":"Topiramate-induced weight loss: a review","volume":"95","author":"Verrotti","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2011.10.001_bib0085","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1214\/aos\/1176350366","article-title":"High breakdown point and high efficiency robust estimates for regression","volume":"15","author":"Yohai","year":"1987","journal-title":"Ann. Stat."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111003068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121111003068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:25:46Z","timestamp":1760275546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121111003068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0920121111003068"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.10.001","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conversion from enzyme-inducing antiepileptic drugs to topiramate: Effects on lipids and c-reactive protein","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}